Comment on: The Feasibility and Outcomes of Metabolic and Bariatric Surgery Prior to Neoplastic Therapy

New therapies are constantly changing the treatment paradigm for neoplastic processes. National guidelines may update multiple times a year to address these shifts1. Parallel to these advancements, drug therapy for patients with obesity and advancements in metabolic and bariatric surgery (MBS) provide mechanisms to achieve sustainable weight loss and address co-morbid conditions. As healthcare continues to shift to improve delivery and patient outcomes, it ’s imperative to consider disparities that might exists for patients with obesity.
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Tags: Editorial Source Type: research